Effect of Chinese herbal medicine (CHM) as an adjunctive therapy in distinct stages of patients with COVID-19: A systematic review and meta-analysis.

ABSTRACT:

Background

The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of infected cases and deaths worldwide. Clinical practice and clinical trials in China suggested that integrated Chinese herbal medicine (CHM) and conventional Western monotherapy (ICW) have achieved significant clinical effectiveness in treating COVID-19 patients.

Objectives

This article aims to systematically evaluate the effects of ICW in treating patients at distinct stages of COVID-19. The most frequently used components of the CHM formulas have been summarized to define the most promising drug candidates.

Methods

In this meta-analysis, seven databases up to May 20, 2024, were systematically searched to collect

SUBMITTER: Gu JM 

PROVIDER: S-EPMC11825027 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature